Articles From: Acadia Realty Trust Announces Special Cash Dividend of $0.30 for 2014 to Accenture and Exelon Rollout State of the Art Mobile Technology Solution


Acadia Realty Trust (NYSE:AKR) today announced that its Board of Trustees has declared a special cash dividend of $0.30 per Common Share payable on January 15, 2015 to holders of record as of December 31, 2014.
Sign-up for Acadia Realty Trust Announces Special Cash Dividend of $0.30 for 2014 investment picks
2015/1/16
Acadia Realty Trust (NYSE:AKR – “Acadia” or the “Company”) has determined that the Federal tax treatment for 2014 distributions to holders of its common shares of beneficial interest (CUSIP # 004239109) traded on the NYSE under the ticker symbol “AKR” is as follows: The regular and special distributions that the Company paid on January 15, 2015, to shareholders of record as of December 31, 2014, are reportable in 2014.
Sign-up for Acadia Realty Trust Announces Tax Reporting Information for 2014 Distributions investment picks
Acadia Realty Trust (NYSE:AKR) today reported operating results for the quarter ended September 30, 2014.
Sign-up for Acadia Realty Trust Reports Third Quarter 2014 Operating Results investment picks
Acadia Realty Trust (NYSE:AKR), will release its fourth quarter 2014 earnings on Tuesday, February 17, 2015 after market close.
Sign-up for Acadia Realty Trust to Announce Fourth Quarter 2014 Earnings on February 17, 2015 investment picks
2014/10/27
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0974997001&sourceType=1 http://www.ccnmatthews.com/logos/20091230-Acadian200.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Acadian Timber Corp. Reports Third Quarter Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0987200001&sourceType=1 http://www.ccnmatthews.com/logos/20091230-Acadian200.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Acadian Timber Corp.: Notice-2014 Fourth Quarter and Year-End Results Conference Call and Webcast for Investors and Analysts investment picks
LAVAL, Quebec, Oct.
Sign-up for Acasti Announces Grant of Stock Options investment picks
LAVAL, Quebec, Oct.
Sign-up for Acasti Announces Second Quarter Results investment picks
LAVAL, Quebec, Jan.
Sign-up for Acasti Announces Third Quarter Results investment picks
LAVAL, Quebec, Nov.
Sign-up for Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements investment picks
Enabling system flexibility and platform scalability for industrial control applications such as digital power, renewable energy and automotive control HOUSTON , Oct.
Sign-up for Accelerate control systems and increase integration while decreasing system cost with TI's new C2000™ Piccolo™ F2807x MCUs investment picks
TUCSON, Ariz., Jan.
Sign-up for Accelerate Diagnostics to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
Brazil's C2 CPA Network selects CAKE by Accelerize as its SaaS-based performance marketing solution NEWPORT BEACH, Calif.
Sign-up for Accelerize Inc. Extends its Footprint in Latin America investment picks
Third quarter revenues increase 71.0% year over year to reach a record $4.3MM, with expected full-year revenues between $16.2MM and $16.4MM NEWPORT BEACH, Calif.
Sign-up for Accelerize Inc. Reports Third Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201411/290524_ACLZ_Logo-300x120.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158597&ProfileId=051205&sourceType=1 NEWPORT BEACH, CA --
Sign-up for Accelerize Inc. Reports Third Quarter 2014 Financial Results investment picks
Rosenthal Brings More Than 15 Years Experience Driving Revenues for High-Growth Technology Companies, Including AOL, DoubleClick and OpenX NEWPORT BEACH, Calif.
Sign-up for Accelerize Names Eric Rosenthal Executive Vice President of Sales of Its CAKE Software Division to Spearhead Global Sales Force Expansion investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced that data in four abstracts on investigational protein therapeutics sotatercept and luspatercept will be presented by Acceleron, its collaboration partner Celgene and clinical investigators at the 56 th American Society of Hematology (ASH) Annual Meeting and Exposition.
Sign-up for Acceleron Announces New Clinical Data Presentations at the 2014 American Society of Hematology Annual Meeting investment picks
Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that its collaboration partner, Celgene, and investigators on the sotatercept program will present preclinical and interim clinical data at the American Society of Nephrology (ASN) Kidney Week 2014.
Sign-up for Acceleron Collaboration Partner Celgene to Present Data at the American Society of Nephrology Kidney Week 2014 investment picks
Acceleron Pharma Inc. (NASDAQ: XLRN), a biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it has been selected for addition to the NASDAQ Biotechnology Index ® (NASDAQ: NBI), effective Monday, December 22, 2014.
Sign-up for Acceleron Pharma Added to NASDAQ Biotechnology Index investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced the appointment of Francois Nader, M.D., M.B.A, to its Board of Directors.
Sign-up for Acceleron Pharma Appoints Dr. Francois Nader to its Board of Directors investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced its major corporate research and development objectives for 2015.
Sign-up for Acceleron Pharma Outlines Corporate Objectives for 2015 investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today provided a corporate update and reported financial results for the third quarter ended September 30, 2014.
Sign-up for Acceleron Pharma Reports Third Quarter 2014 Financial and Operational Results investment picks
Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced that the company will host a conference call and live audio webcast to report its third quarter 2014 financial results and provide a corporate update on Friday, November 7, 2014, at 9:00 AM EST.
Sign-up for Acceleron Pharma to Host Third Quarter 2014 Financial Results Conference Call and Webcast on November 7, 2014 investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will participate in several upcoming investor conferences.
Sign-up for Acceleron Pharma to Present at Upcoming Investor Conferences in December investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will participate in several upcoming investor conferences.
Sign-up for Acceleron Pharma to Present at Upcoming Investor Conferences in November investment picks
It will be a better new year for 3,500 people looking for work in 2015 as Accenture (NYSE:ACN) and Ashoka launch the Talent Growth Initiative (TGI), which not only provides skills training to unemployed and underemployed individuals, it helps place them in jobs.
Sign-up for Accenture and Ashoka Launch New Initiative to Place 3,500 Skilled Workers in Jobs investment picks
Accenture (NYSE:ACN) and Backbase, a leading provider of customer experience management technology solutions, have entered into an alliance agreement in financial services to enable banking clients to improve customer engagement through digital channels.
Sign-up for Accenture and Backbase Form Alliance in Financial Services to Help Banks Improve Customer Engagement through Digital Channels investment picks
Exelon, the nation’s largest private operator of nuclear power plants, has collaborated with Accenture (NYSE:ACN) to implement a mobile technology solution to enhance the productivity of its workforce and increase efficiencies in plant operations and maintenance.
Sign-up for Accenture and Exelon Rollout State of the Art Mobile Technology Solution investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Acadia Realty Trust Announces Special Cash Dividend of $0.30 for 2014 to Accenture and Exelon Rollout State of the Art Mobile Technology Solution
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent